IMPULSE DYNAMICS REACHES MILESTONE WITH 9,000TH PATIENT RECEIVING CCM THERAPY FOR HEART FAILURE

KUALA LUMPUR, May 16 (Bernama) -- Global medical device company, Impulse Dynamics plc, announced a worldwide milestone achievement with the 9,000th patient receiving the Optimizer system for the treatment of moderate heart failure (HF).

The Optimizer system is the only device approved by the US Food and Drug Administration (FDA) in the United States to deliver cardiac contractility modulation (CCM) therapy.

A cardiologist and the President of Stern Cardiovascular, Dr Steven Gubin is part of the care team that completed the procedure at Baptist Memorial Hospital-Memphis, offering CCM therapy to a patient living with the debilitating effects of HF.

According to Impulse Dynamics in a statement, this milestone highlights the momentum building globally for CCM therapy, using the Optimizer platform to improve quality of life in HF patients.

Dr Gubin said: “One of my heart failure patients, Aubretta Bean, who is a cancer survivor, continued to have symptoms despite her compliance with guideline-directed medical therapy for heart failure.

“She let me know that she felt better almost immediately after receiving the implant and continues to improve daily. It has been extremely rewarding to see such improvement in her quality of life,” he added.

Meanwhile, Impulse Dynamics chief executive officer, Simos Kedikoglou said: “We are inspired by such stories highlighting the potential for clinicians to use CCM therapy to make a positive impact on HF patients’ lives.

“The growing cadence of implants and the emergence of such inspiring stories reinforces our commitment to delivering meaningful advances in CCM technology and clinical data.”

Drs Eric Johnson, David Lan and Chris Ingelmo are all electrophysiologists at Stern Cardiovascular that have treated 10 patients at Baptist Memorial Hospital-Memphis with CCM therapy since March 2023. Dr Ingelmo completed the milestone procedure for the 9,000th patient treated with CCM therapy.

The latest generation of the company’s proprietary Optimizer platform is the Optimizer Smart Mini, which offers a rechargeable battery with 20-year battery life and a smaller size designed to make the implant procedure faster and easier for patients and physicians.

-- BERNAMA